Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and Outcomes

Sira Mongkolrat; Adisak Tantiworawit; Piangrawee Niprapan; Pokpong Piriyakhuntorn; Teerachat Punnachet; Nonthakorn Hantrakun; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada

doi:10.12659/AOT.944043

23 July 2024 : Original article

Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and Outcomes

Sira Mongkolrat^1ABCDEF, Adisak Tantiworawit

^2ADE*, Piangrawee Niprapan

^2E, Pokpong Piriyakhuntorn

^3BDE, Teerachat Punnachet

^2E, Nonthakorn Hantrakun

^2E, Thanawat Rattanathammethee

^2E, Sasinee Hantrakool

^2E, Chatree Chai-Adisaksopha

^2E, Ekarat Rattarittamrong

^2E, Lalita Norasetthada

^2E

DOI: 10.12659/AOT.944043

Ann Transplant 2024; 29:e944043

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 (A) Overall survival in engraftment syndrome and non-engraftment syndrome groups. (B) Relapse-free survival in engraftment syndrome and non-engraftment syndrome groups (Stata 17.0, StataCorp LLC, College Station, TX, USA).

Back to the Article

Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and Outcomes

Your Privacy